NasdaqCM - Nasdaq Real Time Price • USD
Minerva Neurosciences, Inc. (NERV)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:18 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.2 | -0.77 | -3.57 | -4.54 |
| Low Estimate | -1.2 | -0.77 | -3.57 | -4.54 |
| High Estimate | -1.2 | -0.77 | -3.57 | -4.54 |
| Year Ago EPS | -1.31 | -1.12 | -4.61 | -3.57 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.63 | -0.44 | -0.77 | -0.88 |
| EPS Actual | -1.31 | -1.12 | -1.03 | -1.39 |
| Difference | 0.32 | -0.68 | -0.26 | -0.51 |
| Surprise % | 19.60% | -154.50% | -33.80% | -58.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.2 | -0.77 | -3.57 | -4.54 |
| 7 Days Ago | -1.2 | -0.77 | -3.57 | -4.54 |
| 30 Days Ago | -1.2 | -0.77 | -3.57 | -4.54 |
| 60 Days Ago | -1.01 | -0.77 | -3.46 | -4.48 |
| 90 Days Ago | -1.01 | -0.77 | -3.46 | -4.48 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NERV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 8.40% | -- | -- | 1.60% |
| Next Qtr. | 31.30% | -- | -- | 10.50% |
| Current Year | 22.60% | -- | -- | 5.20% |
| Next Year | -27.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/27/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 8/2/2023 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 5/16/2023 |
| Reiterates | HC Wainwright & Co.: Neutral | 5/2/2023 |
| Reiterates | HC Wainwright & Co.: Neutral | 3/9/2023 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/10/2022 |
Related Tickers
TIL Instil Bio, Inc.
10.64
+3.30%
PULM Pulmatrix, Inc.
1.9897
+2.04%
NXTC NextCure, Inc.
1.6000
+1.91%
ACHL Achilles Therapeutics plc
0.7829
-2.14%
SYBX Synlogic, Inc.
1.8700
+2.75%
PRTC PureTech Health plc
26.15
-0.46%
RPHM Reneo Pharmaceuticals, Inc.
1.7400
-1.14%
ASMB Assembly Biosciences, Inc.
13.41
+0.60%
CLRB Cellectar Biosciences, Inc.
3.0300
-0.33%
TBPH Theravance Biopharma, Inc.
9.34
+1.52%